{"id":9027,"date":"2024-01-09T14:16:00","date_gmt":"2024-01-09T14:16:00","guid":{"rendered":"https:\/\/dailyai.com\/?p=9027"},"modified":"2024-01-10T09:17:28","modified_gmt":"2024-01-10T09:17:28","slug":"nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo","status":"publish","type":"post","link":"https:\/\/dailyai.com\/es\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","title":{"rendered":"NVIDIA ampl\u00eda su oferta de modelos de descubrimiento de f\u00e1rmacos a trav\u00e9s de BioNeMo"},"content":{"rendered":"<p><b>NVIDIA ha a\u00f1adido nuevos modelos generativos de IA a BioNeMo, un servicio en la nube que permite crear e implantar modelos de IA para el descubrimiento de f\u00e1rmacos.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">BioNeMo es una plataforma de IA generativa dise\u00f1ada para apoyar el proceso de descubrimiento de f\u00e1rmacos, para el que la IA mostr\u00f3 una enorme aptitud en 2023. <\/span><span style=\"font-weight: 400;\">Alberga una serie de modelos de IA y servicios en la nube espec\u00edficamente adaptados al desarrollo de f\u00e1rmacos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Al utilizar la IA para modelizar componentes moleculares, BioNeMo permite a los investigadores generar nuevas estructuras moleculares que podr\u00edan dar lugar a f\u00e1rmacos eficaces, reduciendo la necesidad de realizar experimentos f\u00edsicos costosos y que requieren mucho tiempo.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Por supuesto, todos estos modelos y servicios est\u00e1n respaldados por la infraestructura de hardware de IA de NVIDIA, l\u00edder en su clase.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">BioNeMo se suma al m\u00e1s amplio <a href=\"https:\/\/www.nvidia.com\/en-gb\/clara\/\" target=\"_blank\" rel=\"noopener\">Plataforma NVIDIA Clara<\/a>. NVIDIA Clara es una plataforma inform\u00e1tica espec\u00edfica para el sector sanitario dise\u00f1ada para aprovechar la potencia de la IA y la computaci\u00f3n avanzada para afrontar los retos de la industria sanitaria.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La plataforma Clara es fundamental para la estrategia de IA generativa de la compa\u00f1\u00eda en el \u00e1mbito de la salud -que, seg\u00fan NVIDIA, lleva m\u00e1s de una d\u00e9cada gest\u00e1ndose- y ofrece herramientas y marcos optimizados espec\u00edficamente para aplicaciones de imagen m\u00e9dica, an\u00e1lisis gen\u00f3mico, descubrimiento de f\u00e1rmacos y otras \u00e1reas relacionadas con la salud.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kimberly Powell, vicepresidenta del \u00e1rea de sanidad de NVIDIA, explica lo siguiente sobre BioNeMo: \"La sanidad es intr\u00ednsecamente complicada. Nuestro objetivo es facilitar la labor de los investigadores, que pueden afinar estos modelos en datos propios, ejecutar la inferencia de modelos de IA a trav\u00e9s de navegadores web o API en la nube y acceder a modelos preentrenados para el desarrollo de f\u00e1rmacos.\"\u00a0<\/span><\/p>\n<h2>Una selecci\u00f3n de modelos biotecnol\u00f3gicos y sanitarios<\/h2>\n<p><span style=\"font-weight: 400;\">El conjunto de herramientas de BioNeMo es impresionante, desde el modelo MolMIM de NVIDIA, experto en la generaci\u00f3n de mol\u00e9culas peque\u00f1as, hasta Phenom-Beta de Recursion, un modelo l\u00edder en la incrustaci\u00f3n de im\u00e1genes de microscop\u00eda celular.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Recursion es la primera empresa en ofrecer un modelo de IA a trav\u00e9s de las API en la nube BioNeMo de NVIDIA. Phenom-Beta extrae caracter\u00edsticas de las im\u00e1genes de microscop\u00eda celular, lo que proporciona una visi\u00f3n m\u00e1s profunda de las funciones celulares y de c\u00f3mo reaccionan las c\u00e9lulas a los f\u00e1rmacos o las modificaciones gen\u00e9ticas.<\/span><\/p>\n<figure id=\"attachment_9028\" aria-describedby=\"caption-attachment-9028\" style=\"width: 1024px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-9028 size-large\" src=\"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-1024x515.gif\" alt=\"IA NVIDIA\" width=\"1024\" height=\"515\" srcset=\"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-1024x515.gif 1024w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-300x151.gif 300w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-768x386.gif 768w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-370x186.gif 370w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-800x402.gif 800w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-740x372.gif 740w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-20x10.gif 20w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-96x48.gif 96w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption id=\"caption-attachment-9028\" class=\"wp-caption-text\">Phenom-Beta supera las tareas de reconstrucci\u00f3n de im\u00e1genes que eval\u00faan el rendimiento del modelo. Fuente: <a href=\"https:\/\/blogs.nvidia.com\/blog\/drug-discovery-bionemo-generative-ai\/\" target=\"_blank\" rel=\"noopener\">NVIDIA<\/a>.<\/figcaption><\/figure>\n<p><a href=\"https:\/\/blogs.nvidia.com\/blog\/drug-discovery-bionemo-generative-ai\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Seg\u00fan NVIDIA<\/span><\/a><span style=\"font-weight: 400;\">, Recursion est\u00e1 mejorando sus recursos de supercomputaci\u00f3n con la incorporaci\u00f3n de m\u00e1s de 500 GPU NVIDIA H100 a su sistema, lo que cuadruplicar\u00e1 su capacidad de c\u00e1lculo. Ser\u00e1 uno de los superordenadores m\u00e1s potentes del sector biofarmac\u00e9utico.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El descubrimiento de f\u00e1rmacos se ha convertido en uno de los principales puntos fuertes de la IA generativa en el sector cient\u00edfico. <\/span><a href=\"https:\/\/dailyai.com\/es\/2023\/06\/researchers-build-breakthrough-ai-model-for-drug-discovery\/\"><span style=\"font-weight: 400;\">nuevas clases de antibi\u00f3ticos<\/span><\/a><span style=\"font-weight: 400;\">identificando <\/span><a href=\"https:\/\/dailyai.com\/es\/2023\/07\/ai-accelerates-discovery-of-anti-aging-drugs-in-new-study\/\"><span style=\"font-weight: 400;\">compuestos capaces de retrasar el envejecimiento<\/span><\/a><span style=\"font-weight: 400;\">y <\/span><a href=\"https:\/\/dailyai.com\/es\/2023\/12\/astrazeneca-bets-247m-on-ai-company-developing-cancer-drug\/\"><span style=\"font-weight: 400;\">desarrollo de medicamentos contra el c\u00e1ncer<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Gracias a su capacidad para procesar grandes cantidades de datos y extraer de ellos nuevos conocimientos, la IA generativa est\u00e1 cumpliendo su promesa hom\u00f3nima de generar nuevas v\u00edas para la investigaci\u00f3n m\u00e9dica y biotecnol\u00f3gica.<\/span><\/p>\n<p>Esto se produce cuando NVIDIA <a href=\"https:\/\/dailyai.com\/es\/2024\/01\/nvidia-announces-new-chips-and-tools-for-on-device-ai\/\">anuncia nuevas GPU y hardware<\/a> para el procesamiento local de IA en el dispositivo.<\/p>","protected":false},"excerpt":{"rendered":"<p>NVIDIA ha a\u00f1adido nuevos modelos generativos de IA a BioNeMo, un servicio en la nube para crear e implantar modelos de IA para el descubrimiento de f\u00e1rmacos. BioNeMo es una plataforma de IA generativa dise\u00f1ada para apoyar el proceso de descubrimiento de f\u00e1rmacos, para el que la IA mostr\u00f3 una enorme aptitud en 2023. Alberga una serie de modelos de IA y servicios en la nube espec\u00edficamente adaptados al desarrollo de f\u00e1rmacos. Al utilizar la IA para modelar componentes moleculares, BioNeMo permite a los investigadores generar nuevas estructuras moleculares que podr\u00edan dar lugar a f\u00e1rmacos eficaces, reduciendo la necesidad de realizar experimentos f\u00edsicos costosos y que requieren mucho tiempo.  Por supuesto, todos estos modelos y servicios est\u00e1n respaldados por la tecnolog\u00eda de IA de NVIDIA, l\u00edder en su clase.<\/p>","protected":false},"author":2,"featured_media":1059,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83],"tags":[203,260,204,101,106],"class_list":["post-9027","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product","tag-biotech","tag-drug-discovery","tag-healthcare","tag-medtech","tag-nvidia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI<\/title>\n<meta name=\"description\" content=\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/es\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI\" \/>\n<meta property=\"og:description\" content=\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/es\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-09T14:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-10T09:17:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sam Jeans\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sam Jeans\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"},\"author\":{\"name\":\"Sam Jeans\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/711e81f945549438e8bbc579efdeb3c9\"},\"headline\":\"NVIDIA expands offerings of drug discovery models through BioNeMo\",\"datePublished\":\"2024-01-09T14:16:00+00:00\",\"dateModified\":\"2024-01-10T09:17:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"},\"wordCount\":442,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"keywords\":[\"Biotech\",\"Drug discovery\",\"Healthcare\",\"MedTech\",\"Nvidia\"],\"articleSection\":[\"Product\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\",\"name\":\"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"datePublished\":\"2024-01-09T14:16:00+00:00\",\"dateModified\":\"2024-01-10T09:17:28+00:00\",\"description\":\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"width\":1000,\"height\":667,\"caption\":\"Nvidia AI products\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NVIDIA expands offerings of drug discovery models through BioNeMo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/711e81f945549438e8bbc579efdeb3c9\",\"name\":\"Sam Jeans\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"caption\":\"Sam Jeans\"},\"description\":\"Sam is a science and technology writer who has worked in various AI startups. When he\u2019s not writing, he can be found reading medical journals or digging through boxes of vinyl records.\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/sam-jeans-6746b9142\\\/\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/es\\\/author\\\/samjeans\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NVIDIA ampl\u00eda su oferta de modelos de descubrimiento de f\u00e1rmacos a trav\u00e9s de BioNeMo | DailyAI","description":"NVIDIA ha a\u00f1adido nuevos modelos generativos de IA a BioNeMo, un servicio en la nube que permite crear e implantar modelos de IA para el descubrimiento de f\u00e1rmacos.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/es\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","og_locale":"es_ES","og_type":"article","og_title":"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI","og_description":"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.","og_url":"https:\/\/dailyai.com\/es\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","og_site_name":"DailyAI","article_published_time":"2024-01-09T14:16:00+00:00","article_modified_time":"2024-01-10T09:17:28+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","type":"image\/jpeg"}],"author":"Sam Jeans","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Escrito por":"Sam Jeans","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"},"author":{"name":"Sam Jeans","@id":"https:\/\/dailyai.com\/#\/schema\/person\/711e81f945549438e8bbc579efdeb3c9"},"headline":"NVIDIA expands offerings of drug discovery models through BioNeMo","datePublished":"2024-01-09T14:16:00+00:00","dateModified":"2024-01-10T09:17:28+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"},"wordCount":442,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","keywords":["Biotech","Drug discovery","Healthcare","MedTech","Nvidia"],"articleSection":["Product"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","url":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","name":"NVIDIA ampl\u00eda su oferta de modelos de descubrimiento de f\u00e1rmacos a trav\u00e9s de BioNeMo | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","datePublished":"2024-01-09T14:16:00+00:00","dateModified":"2024-01-10T09:17:28+00:00","description":"NVIDIA ha a\u00f1adido nuevos modelos generativos de IA a BioNeMo, un servicio en la nube que permite crear e implantar modelos de IA para el descubrimiento de f\u00e1rmacos.","breadcrumb":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","width":1000,"height":667,"caption":"Nvidia AI products"},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"NVIDIA expands offerings of drug discovery models through BioNeMo"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DailyAI","description":"Su dosis diaria de noticias sobre IA","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DailyAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/711e81f945549438e8bbc579efdeb3c9","name":"Sam Jeans","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","caption":"Sam Jeans"},"description":"Sam es un escritor de ciencia y tecnolog\u00eda que ha trabajado en varias startups de IA. Cuando no est\u00e1 escribiendo, se le puede encontrar leyendo revistas m\u00e9dicas o rebuscando en cajas de discos de vinilo.","sameAs":["https:\/\/www.linkedin.com\/in\/sam-jeans-6746b9142\/"],"url":"https:\/\/dailyai.com\/es\/author\/samjeans\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts\/9027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/comments?post=9027"}],"version-history":[{"count":9,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts\/9027\/revisions"}],"predecessor-version":[{"id":9063,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts\/9027\/revisions\/9063"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/media\/1059"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/media?parent=9027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/categories?post=9027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/tags?post=9027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}